Researchers investigate rare side effect of blood cancer immunotherapy
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...
emjreviews.com19 小时
Enhancing Immunotherapy by Targeting Specific Receptors in Ovarian Cancer
Discover a study that describes a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.
Battling cancer can kill your social life — but it also taught me one vital lesson
As part of the Daily Express's campaign for better mental health provisions for cancer patients, Robert Fisk offers a candid ...
idw18 小时
Rare side effect of cancer immunotherapy
Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer ...
emjreviews.com13 小时
New Strategy Enhances PD-1 Therapy in Treatment-Resistant Cancers
A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
manilatimes16 小时
Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug ...
MB310 has been developed as an oral capsule, dosed once daily, containing a defined consortium of eight live gut commensal ...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
Veterinary Medicine Market Expected To Hit USD 62.54 Billion By 2034 With A Remarkable 5.62 ...
Veterinary Medicine Market Veterinary Medicine Market Caring for Animal Health, a Growing Market. US, NY, UNITED STATES, February 21, 2 ...